# The ASCO Post

Source: https://onco.cc/collections/src-asco-post/  
OnCo record `src-asco-post` (Collection). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The ASCO Post gives reliable, clinician-written summaries of the trials that matter, usually within days.

## Summary

The ASCO Post carries news and expert commentary on trials, approvals, guidelines and oncology leadership, with clinician-written summaries of the trials that matter usually appearing within days. It is published by Harborside with ASCO, printing twice monthly and publishing daily online, and is free to read. It offers a good balance of data and expert perspective, and its congress coverage is thorough. On OnCo it is listed as a source with the tags source and news.

## Fields

- Kind: Collection
- Last checked: 2026-09-08
- Tags: source; news
- URL: https://ascopost.com/
- Holds: News and expert commentary on trials, approvals, guidelines, and oncology leadership.
- Licence: Free

## Sources

- The ASCO Post: https://ascopost.com/

## Connected records

- trials: [EMERALD-3](https://onco.cc/trials/emerald-3/), [KEYNOTE-B96 / ENGOT-ov65](https://onco.cc/trials/keynote-b96/), [KOMET-001](https://onco.cc/trials/komet-001/), [SERENA-6](https://onco.cc/trials/serena-6/)
- institutions: [American Society of Clinical Oncology (ASCO)](https://onco.cc/institutions/asco/)

---
JSON: https://onco.cc/api/v1/entities/src-asco-post.json